A dermatooncology research group driving innovation in melanoma prevention, detection, and mangament through AI-powered imaging and biomarker advancements.
Our research focuses on prevention, early detection and management of melanoma as well as surveillance of high-risk individuals. The increasing global incidence of melanoma and the remaining high mortality emphasizes the urgent need to improve skin cancer awareness and early diagnostic techniques. We investigate innovative non-invasive diagnostic imaging approaches utilizing artificial intelligence (AI) in combination with established methods to enhance skin cancer diagnostics. Also psychological distress in skin cancer patients as well as rare skin tumors, e.g. Kaposi sarcoma and Merkel cell carcinoma, belong to our research field. We aim for future translational research approaches to combine novel AI-driven imaging tools with biomarker assessment to identify individuals at highest risk who require enhanced prevention and detection to improve patient care and health outcomes of melanoma.